{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:47:50Z","timestamp":1787784470129,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1136\/ijgc-2024-005964","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T13:25:18Z","timestamp":1730726718000},"page":"101870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery"],"prefix":"10.1016","volume":"36","author":[{"given":"Eliane","family":"Aoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrett","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Awujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Nebgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth R.","family":"Soletsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary B.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-9441","authenticated-orcid":false,"given":"Roni Nitecki","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005964_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2024-005964_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/OP.21.00382","article-title":"Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes","volume":"18","author":"Liu","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1136\/ijgc-2024-005964_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ygyno.2019.11.036","article-title":"Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations","volume":"156","author":"Solsky","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005964_bib4","first-page":"102","article-title":"Serous Tubal Intraepithelial Carcinoma: A Concise Review for the Practicing Pathologist and Clinician","volume":"10","author":"Bachert","year":"2020","journal-title":"Diagn (Basel)"},{"key":"10.1136\/ijgc-2024-005964_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky061","article-title":"Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol","volume":"2","author":"Samimi","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"10.1136\/ijgc-2024-005964_bib6","first-page":"3054","article-title":"Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience","volume":"12","author":"Cassani","year":"2022","journal-title":"Diagn (Basel)"},{"key":"10.1136\/ijgc-2024-005964_bib7","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005964_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PGP.0b013e31824cbeb4","article-title":"Ki-67 Labeling Index as an Adjunct in the Diagnosis of Serous Tubal Intraepithelial Carcinoma","volume":"31","author":"Kuhn","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1136\/ijgc-2024-005964_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005964_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejso.2019.09.002","article-title":"Pathological findings following risk- reducing salpingo-oophorectomy in BRCA mutation carriers: A systematic review and meta-analysis","volume":"46","author":"Cheng","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2024-005964_bib11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1136\/ijgc-2024-005964_bib12","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.21.02016","article-title":"Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis","volume":"40","author":"Steenbeek","year":"2022","journal-title":"JCO"},{"key":"10.1136\/ijgc-2024-005964_bib13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cncr.31211","article-title":"Peritoneal carcinomatosis after risk-reducing surgery in BRCA1\/2 mutation carriers","volume":"124","author":"Harmsen","year":"2018","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2024-005964_bib14","series-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic (Version 1.2024)","year":"2023"},{"key":"10.1136\/ijgc-2024-005964_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1136\/ijgc-2024-005964_bib16","series-title":"Ovarian cancer\/ fallopian tube cancer\/primary peritoneal cancer (NCCN Guidelines Version 2.2024)","year":"2024"},{"key":"10.1136\/ijgc-2024-005964_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2024-005964_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1136\/ijgc-2024-005964_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PAS.0000000000002187","article-title":"Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions","volume":"48","author":"Chien","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2024-005964_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2013.12.009","article-title":"Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo- oophorectomy in women with germ-line BRCA1 or BRCA2 mutations","volume":"132","author":"Conner","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005964_bib21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/IGC.0000000000000791","article-title":"Incidence and Characteristics of Unsuspected Neoplasia Discovered in High-Risk Women Undergoing Risk Reductive Bilateral Salpingooophorectomy","volume":"26","author":"Poon","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005964_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the \u201cfallopian tube hypothesis\u201d in a prospective series of risk-reducing salpingo-oophorectomy specimens","volume":"49","author":"Reitsma","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2024-005964_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2016.08.336","article-title":"Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers","volume":"143","author":"Zakhour","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005964_bib24","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","article-title":"Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management","volume":"16","author":"Weinberger","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1136\/ijgc-2024-005964_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clon.2018.03.036","article-title":"Outcome and Prognostic Impact of Surgical Staging in Serous Tubal Intraepithelial Carcinoma: A Cohort Study and Systematic Review","volume":"30","author":"Van der Hoeven","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1136\/ijgc-2024-005964_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2021.08.021","article-title":"Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC)","volume":"163","author":"Saccardi","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005964_bib27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/ijgc-2023-004618","article-title":"Pathological findings and long- term prognosis in Korean BRCA1\/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy","volume":"33","author":"Kang","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2024-005964_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2019.03.003","article-title":"Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up","volume":"153","author":"Blok","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005964_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13048-019-0525-1","article-title":"Development of Peritoneal Carcinoma in Women Diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) Following Risk-Reducing Salpingo-Oophorectomy (RRSO)","volume":"12","author":"Stanciu","year":"2019","journal-title":"J Ovarian Res"},{"key":"10.1136\/ijgc-2024-005964_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","article-title":"Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non- randomised multicentre study","volume":"15","author":"Harmsen","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1136\/ijgc-2024-005964_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.04.055","article-title":"WISP: A prospective, multi- center trial of salpingectomy with delayed oophorectomy versus risk reducing salpingo-oophorectomy in women at increased risk for hereditary ovarian cancer","volume":"154","author":"Lu","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25009892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25009892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:18:55Z","timestamp":1780003135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25009892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1048891X25009892"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005964","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"101870"}}